RJV Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Somnomed Ltd

Watchlist Manager

Watchlist

Price: 0.195 EUR -7.14% Market Closed

Market Cap: €42.1m

	Somnomed Ltd F:RJV	AU
	Immix Biopharma Inc NASDAQ:IMMX	US
S	SCB X PCL SET:SCB	TH
E	EA Holdings Bhd KLSE:EAH	MY
O	Ormat Technologies Inc SWB:HNM	US

Profitability Summary

Somnomed Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

60%

Strong 3Y Average Gross Margin

60%

Declining Gross Margin

62% > 60%

Low Operating Margin

Negative 3Y Average Operating Margin

-4%

Operating Margin is Increasing

-5% > 1%

Negative Net Margin

-2%

Negative 3Y Average Net Margin

-7%

Net Margin is Increasing

-10% > -2%

Healthy Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-4%

Free Cash Flow Margin is Increasing

-12% > 2%

Negative ROE

-5%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-2%

ROIC is Increasing

-13% > 41%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.